000			02084 a2200541 4500
005			20250517045959.0
264		0	_c20160815
008			201608s 0 0 eng d
022			_a2352-3964
024	7		_a10.1016/j.ebiom.2015.04.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aUckun, Fatih M
245	0	0	_aLiposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice. _h[electronic resource]
260			_bEBioMedicine _cJun 2015
300			_a554-62 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBone Marrow Transplantation
650	0	4	_aCell Line, Tumor
650	0	4	_aCombined Modality Therapy _xmethods
650	0	4	_aDisease-Free Survival
650	0	4	_aFusion Proteins, bcr-abl _xgenetics
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aHumans
650	0	4	_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors
650	0	4	_aLiposomes _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aMice, Transgenic
650	0	4	_aNanoparticles
650	0	4	_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xmortality
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aRadiation Tolerance _xdrug effects
650	0	4	_aRadiation-Sensitizing Agents _xtherapeutic use
650	0	4	_aSyk Kinase
650	0	4	_aTreatment Outcome
650	0	4	_aWhole-Body Irradiation
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aMyers, Dorothea E
700	1		_aCheng, Jianjun
700	1		_aQazi, Sanjive
773	0		_tEBioMedicine _gvol. 2 _gno. 6 _gp. 554-62
856	4	0	_uhttps://doi.org/10.1016/j.ebiom.2015.04.005 _zAvailable from publisher's website
999			_c25181246 _d25181246